ARTICLE | Clinical News
Inviragen preclinical data
November 15, 2010 8:00 AM UTC
In mouse models of CHIKV infection, Inviragen's chikungunya virus vaccine was safe and generated protective neutralizing antibody responses after a single dose. Additionally, 100% of mice immunized wi...